과학
중도 성향
STAT+: Abivax seeks to ease safety concerns with new data, boosting shares
STAT News
조회 0
이 뉴스, 어떠셨어요?
한 번의 탭으로 반응을 남겨요 · 로그인 불필요
Safety concerns tied to Abivax's experimental bowel disease drug tanked company shares just weeks ago.
But a new analysis sent them climbing. ...
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.
'science' 카테고리 뉴스
Opinion: Short-sighted new student loan caps elevate chiropractic care over critical health care professions
STAT News
STAT+: The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk
STAT News
Opinion: Florida is the first state to require EKGs for high school athletes. It’s a mistake
STAT News